Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Exclusive: TCG, DCVC and Lux back new autoimmune biotech from Kallyope co-founder
10 months ago
Financing
Startups
Japanese government grants Shinobi $59M for cell therapy development
10 months ago
Financing
Merck enlists partner Daiichi Sankyo to develop T cell engager from Harpoon acquisition
10 months ago
Deals
Pharma
A new Apple Tree Partners biotech launches with $55M to make ‘pan-variant’ antivirals
10 months ago
Financing
Startups
Bayer details 3,200 job cuts so far, spotlights ‘momentum’ in pharma pipeline
10 months ago
Pharma
Ultimovacs’ cancer vaccine flunks again — this time in head and neck cancer
10 months ago
R&D
Exclusive: Biotech investor Sofinnova hires former Biogen medical chief
10 months ago
People
BioMarin scales back launch for hemophilia gene therapy, pitches path to profitability
10 months ago
R&D
Pharma
Eliot Forster’s pain biotech unveils Phase 2 data in degenerative joint disease
10 months ago
R&D
Nuvation pauses BET inhibitor plans after checking out interim Phase 1 data
10 months ago
R&D
Mallinckrodt sells photopheresis platform Therakos for $925M
10 months ago
Deals
Bristol Myers to cut more jobs at headquarters as part of announced restructure
10 months ago
People
Pharma
Q&A: Genentech's new CEO on AI, IRA and radiopharma
10 months ago
People
R&D
Third Rock and Arie Belldegrun’s firm come together for CD20/CD3 bispecific out of China
10 months ago
Startups
Deals
What the meltdown in the stock market means for biotech and pharma
10 months ago
Deals
Pharma
Layoffs at Sumitomo; Galderma and L’Oréal strike a deal
10 months ago
News Briefing
MBX Biosciences rakes in $63.5M for peptide therapies
10 months ago
Financing
FDA wants new trial of Actinium’s radioactive iodine drug, company to seek partner
10 months ago
R&D
Pharma
Florida CNS gene therapy biotech shuts down
10 months ago
People
Startups
Bayer plans label expansion for Kerendia after Phase 3 win in heart failure
10 months ago
R&D
Pharma
BioNTech says no to Phase 3 with Genmab’s bispecific antibody
10 months ago
Deals
R&D
Bristol Myers returns TIGIT bispecific to Agenus, frees itself from $1B+ milestones
10 months ago
Deals
R&D
Eisai’s new Leqembi data; Jim Wilson’s next move; Roivant dealmaker’s payday; What’s next for MDMA?; and more
10 months ago
Weekly
Advisory committee votes in favor of Zevra Therapeutics' rare genetic disease drug
10 months ago
R&D
First page
Previous page
121
122
123
124
125
126
127
Next page
Last page
